Publications by authors named "Gregoire Prevost"

Claim this Profile
S
Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.
Negar Babae, Meriem Bourajjaj, Yijia Liu, Judy R Van Beijnum, Francesco Cerisoli, Gregoire P Prevost

Oncotarget· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability.
Jos B Poell, Rick J van Haastert, Thijs de Gunst, Iman J Schultz, Willemijn M Gommans, Gregoire P Prevost

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability.
Jos B Poell, Rick J van Haastert, Thijs de Gunst, Iman J Schultz, Willemijn M Gommans, Gregoire P Prevost

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
Sylvia Julien, Ana Merino-Trigo, Ludovic Lacroix, Marc Pocard, Diane Goéré

Clin Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
Radia Ouelaa-Benslama, Olivier De Wever, An Hendrix, Michèle Sabbah, Kathleen Lambein

Int J Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity.
Antoine Brouquet, Philippe Taleb, Anne-Sophie Lot, Alain Beauchet, Catherine Julie, Gregoire Prevost

J Surg Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents.
Nicolas Goasguen, Cecile de Chaisemartin, Antoine Brouquet, Catherine Julié, Gregoire P Prevost

Int J Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.
Anne-Frédérique Dessein, Laurence Stechly, Nicolas Jonckheere, Patrick Dumont, Didier Monté

Cancer Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D imaging of the response to CDC25 inhibition in multicellular spheroids.
Céline Frongia, Corinne Lorenzo, Fréderic Gianni, Grégoire Pierre Prevost, Bernard Ducommun

Cancer Biol Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit.
Mohammed Akli Ayoub, Marjorie Damian, Christian Gespach, Eric Ferrandis, Olivier Lavergne

J Biol Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of the CDC25A phosphatase down-stream of the NPM/ALK oncogene participates to anaplastic large cell lymphoma enhanced proliferation.
Anne Fernandez-Vidal, Anne Mazars, Emilie-Fleur Gautier, Grégoire Prévost, Bernard Payrastre

Cell Cycle· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells.
Marie-Christine Brezak, Annie Valette, Muriel Quaranta, Marie-Odile Contour-Galcera, Denis Jullien, Grégoire Pierre Prevost

Int J Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Michèle Sabbah, Shahin Emami, Gérard Redeuilh, Sylvia Julien, Grégoire Prévost

Drug Resist Updat· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preamble: CDC25 phosphatases in cancer and CDC25 inhibitors.
Grégoire Pierre Prevost

Anticancer Agents Med Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine.
Christine Favre-Guilmard, Hamida Zeroual-Hider, Chantal Soulard, Caroline Touvay, Pierre-Etienne Chabrier, Grégoire Prevost

Eur J Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents.
Anne-Marie Liberatore, Hélène Coulomb, Dominique Pons, Olivier Dutruel, Philip G Kasprzyk

Mol Cancer Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and bioevaluation of 22-hydroxyacuminatine analogs.
François Grillet, Barbora Baumlová, Grégoire Prévost, Jean-François Constant, Sophie Chaumeron

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
Simon P Newman, Paul A Foster, Chloe Stengel, Joanna M Day, Yaik T Ho, Gregoire Prevost

Clin Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's new on CDC25 phosphatase inhibitors.
Marie-Odile Contour-Galcera, Alban Sidhu, Grégoire Prévost, Dennis Bigg, Bernard Ducommun

Pharmacol Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly.
Martine Cazales, Rose Boutros, Marie-Christine Brezak, Sophie Chaumeron, Grégoire Prevost

Mol Cancer Ther· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.
Grégoire P Prévost, Marie O Lonchampt, Susan Holbeck, Samir Attoub, Daniel Zaharevitz

Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia.
Anne Fernandez-Vidal, Loïc Ysebaert, Christine Didier, Remy Betous, Fabienne De Toni

Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.
Béatrix Bugler, Muriel Quaranta, Bernadette Aressy, Marie-Christine Brezak, Grégoire Prevost

Mol Cancer Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C.
Olivier Lavergne, Anne-Cécile Fernandes, Laetitia Bréhu, Alban Sidhu, Marie-Christine Brézak

Bioorg Med Chem Lett· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases.
Marie-Christine Brezak, Muriel Quaranta, Marie-Odile Contour-Galcera, Olivier Lavergne, Odile Mondesert, Gregoire P Prevost

Mol Cancer Ther· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis